Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.68)
# 2,027
Out of 4,945 analysts
299
Total ratings
56.43%
Success rate
-1.06%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $133.14 | +8.16% | 15 | Aug 6, 2025 | |
HNGE Hinge Health | Maintains: Overweight | $46 → $57 | $57.19 | -0.33% | 2 | Aug 6, 2025 | |
HCA HCA Healthcare | Maintains: Equal-Weight | $410 → $400 | $393.65 | +1.61% | 4 | Jul 28, 2025 | |
OMDA Omada Health | Initiates: Overweight | $25 | $20.41 | +22.49% | 1 | Jul 1, 2025 | |
HIMS Hims & Hers Health | Reiterates: Equal-Weight | $40 | $47.13 | -15.13% | 4 | Jun 11, 2025 | |
THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $172.36 | +21.84% | 3 | Jun 9, 2025 | |
VEEV Veeva Systems | Maintains: Underweight | $201 → $210 | $274.98 | -23.63% | 8 | May 29, 2025 | |
UHS Universal Health Services | Initiates: Equal-Weight | $200 | $178.74 | +11.89% | 1 | Mar 26, 2025 | |
ARDT Ardent Health | Maintains: Overweight | $24 → $22 | $12.49 | +76.14% | 2 | Jan 21, 2025 | |
AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $7.27 | +44.43% | 5 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $6 | $3.54 | +69.49% | 2 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $3.80 | +31.58% | 12 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $75.36 | +51.27% | 24 | Feb 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $32.47 | +75.55% | 19 | Jun 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $65.99 | +22.75% | 23 | Jun 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $63.54 | -44.92% | 4 | May 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $14.68 | +22.62% | 4 | Mar 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $90.66 | +104.06% | 23 | Feb 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $206.97 | -19.31% | 23 | Jan 27, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $110.74 | -62.07% | 25 | Jan 27, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $178.44 | -10.89% | 2 | Dec 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $66.73 | +87.32% | 3 | Dec 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $311.23 | -76.77% | 22 | Dec 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $193.71 | +0.67% | 3 | Oct 27, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $271.49 | +79.75% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $159.63 | +85.43% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $271.25 | +35.67% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $281.34 | +82.34% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $290.35 | -5.29% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $26.93 | +226.77% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $51.62 | - | 11 | Aug 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $68.03 | +171.94% | 2 | May 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $231.54 | -8.01% | 19 | Apr 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $167.37 | -65.35% | 12 | Feb 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $236.21 | -50.47% | 15 | Jun 16, 2020 |
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $133.14
Upside: +8.16%
Hinge Health
Aug 6, 2025
Maintains: Overweight
Price Target: $46 → $57
Current: $57.19
Upside: -0.33%
HCA Healthcare
Jul 28, 2025
Maintains: Equal-Weight
Price Target: $410 → $400
Current: $393.65
Upside: +1.61%
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $20.41
Upside: +22.49%
Hims & Hers Health
Jun 11, 2025
Reiterates: Equal-Weight
Price Target: $40
Current: $47.13
Upside: -15.13%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $172.36
Upside: +21.84%
Veeva Systems
May 29, 2025
Maintains: Underweight
Price Target: $201 → $210
Current: $274.98
Upside: -23.63%
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $178.74
Upside: +11.89%
Ardent Health
Jan 21, 2025
Maintains: Overweight
Price Target: $24 → $22
Current: $12.49
Upside: +76.14%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $7.27
Upside: +44.43%
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $3.54
Upside: +69.49%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $3.80
Upside: +31.58%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $75.36
Upside: +51.27%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $32.47
Upside: +75.55%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $65.99
Upside: +22.75%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $63.54
Upside: -44.92%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $14.68
Upside: +22.62%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $90.66
Upside: +104.06%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $206.97
Upside: -19.31%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $110.74
Upside: -62.07%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $178.44
Upside: -10.89%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $66.73
Upside: +87.32%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $311.23
Upside: -76.77%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $193.71
Upside: +0.67%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $271.49
Upside: +79.75%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $159.63
Upside: +85.43%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $271.25
Upside: +35.67%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $281.34
Upside: +82.34%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $290.35
Upside: -5.29%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $26.93
Upside: +226.77%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $51.62
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $68.03
Upside: +171.94%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $231.54
Upside: -8.01%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $167.37
Upside: -65.35%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $236.21
Upside: -50.47%